| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/15/1998 | US5807548 Method of treating cancer using a chimera antibody |
| 09/15/1998 | US5807538 Technetium-99m labeled peptides for imaging inflammation |
| 09/15/1998 | US5807537 Medical diagnosis |
| 09/15/1998 | CA2106080C Trk tyrosine kinase receptor is the physiological receptor for nerve growth factor |
| 09/15/1998 | CA1340045C Recombinant escherichia coli that produces bricella o-chain polysaccharide |
| 09/14/1998 | CA2221830A1 Tumor necrosis factor related receptor, tr6 |
| 09/13/1998 | CA2229515A1 Expression of a foamy virus envelope protein |
| 09/13/1998 | CA2199989A1 Expression of a foamy virus envelope protein |
| 09/12/1998 | CA2219964A1 Polypeptide capable of binding interleukin-18 and uses therof |
| 09/11/1998 | WO1998039661A1 Method for identifying hormonally modulated genes |
| 09/11/1998 | WO1998039659A1 Screening and treatment using complement regulator or receptor proteins |
| 09/11/1998 | WO1998039653A1 Methods for producing pure perlecan and other heparan sulfate proteoglycans |
| 09/11/1998 | WO1998039487A1 Novel screening methods to identify agents that selectively inhibit hepatitis c virus replication |
| 09/11/1998 | WO1998039482A1 Fusion proteins comprising bacteriophage coat protein and a single-chain t cell receptor |
| 09/11/1998 | WO1998039476A1 Method of identifying gene encoding type ii membrane protein |
| 09/11/1998 | WO1998039467A2 Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof |
| 09/11/1998 | WO1998039466A2 Adenovirus vectors specific for cells expressing androgen receptor and methods of use thereof |
| 09/11/1998 | WO1998039465A2 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| 09/11/1998 | WO1998039464A2 Adenovirus vectors containing heterologous transcription regulatory elements and methods of using same |
| 09/11/1998 | WO1998039462A1 Method of hybrid seed production using conditional female sterility |
| 09/11/1998 | WO1998039461A1 Methods of commercial production and extraction of protein from seed |
| 09/11/1998 | WO1998039451A1 Feline immunodeficiency virus clone jsy3 |
| 09/11/1998 | WO1998039450A2 SURFACE PROTEIN (SPsA PROTEIN) OF STREPTOCOCCUS PNEUMONIAE, DELETED DERIVATIVES, EXPRESSION SYSTEM FOR SAID PROTEINS AND VACCINE SYSTEM WITH SAID PROTEINS |
| 09/11/1998 | WO1998039449A1 COMPOSITIONS AND USE OF M-CSF-alpha |
| 09/11/1998 | WO1998039448A9 186 human secreted proteins |
| 09/11/1998 | WO1998039448A2 186 human secreted proteins |
| 09/11/1998 | WO1998039447A1 Prostate cancer-specific marker |
| 09/11/1998 | WO1998039446A2 70 human secreted proteins |
| 09/11/1998 | WO1998039445A1 Human tubby homolog |
| 09/11/1998 | WO1998039444A1 Protein kinase c inhibitor-like protein (ipkc-2) |
| 09/11/1998 | WO1998039443A1 Spα: A SCAVENGER RECEPTOR CYSTEINE-RICH DOMAIN-CONTAINING POLYPEPTIDE, AND MONOCLONAL ANTIBODIES THERETO |
| 09/11/1998 | WO1998039442A1 Human mitochondrial membrane protein |
| 09/11/1998 | WO1998039441A1 Human chemokine receptor-like chemokine |
| 09/11/1998 | WO1998039440A2 CALCIUM INDEPENDENT RECEPTOR OF α-LATROTOXIN, CHARACTERIZATION AND USES THEREOF |
| 09/11/1998 | WO1998039439A1 Men1, the gene associated with multiple endocrine neoplasia type 1, menin polypeptides, and uses thereof |
| 09/11/1998 | WO1998039437A1 Novel apoptosis-related dnas |
| 09/11/1998 | WO1998039436A2 Fibroblast growth factor mutein compositions and methods of use therefor |
| 09/11/1998 | WO1998039434A1 Methods and reagents for modulating apoptosis |
| 09/11/1998 | WO1998039433A1 Complement receptor type 1 (cr1)-like sequences |
| 09/11/1998 | WO1998039432A1 Polynucleotides and polypeptides belonging to the uncoupling proteins family |
| 09/11/1998 | WO1998039431A1 Sr-bi regulatory sequences and therapeutic methods of use |
| 09/11/1998 | WO1998039430A1 Methods and compositions for diagnosis and treatment of cancer |
| 09/11/1998 | WO1998039429A2 Compositions for treatment of disorders involving programmed cell death |
| 09/11/1998 | WO1998039426A2 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products |
| 09/11/1998 | WO1998039425A2 Vectors and methods for expression of mutant proteins |
| 09/11/1998 | WO1998039418A1 New applications of gene therapy technology |
| 09/11/1998 | WO1998039413A1 Models for haematopoiesis |
| 09/11/1998 | WO1998039410A1 IλB $i(KINASES) |
| 09/11/1998 | WO1998039363A2 Immunotoxins and methods of inducing immune tolerance |
| 09/11/1998 | WO1998039361A1 A lymphocyte surface receptor that binds caml, nucleic acids encoding the same and methods of use thereof |
| 09/11/1998 | WO1998039360A1 Antigenic structural peptide, antigenic and immunogenic compounds and uses for detecting, preventing and treating an hcv infection |
| 09/11/1998 | WO1998039357A1 Method of alleviating neuropathic pain |
| 09/11/1998 | WO1998039356A1 Purified and recombinant antigenic proteins associated with abdominal aortic aneurysm (aaa) disease |
| 09/11/1998 | WO1998039355A1 Species-specific yeast tfiib sequence |
| 09/11/1998 | WO1998039354A1 Fas ligand compositions for treatment of proliferative disorders |
| 09/11/1998 | WO1998039090A1 Polyasparaginic acid homopolymers and copolymers, biotechnical production and use thereof |
| 09/11/1998 | WO1998039031A1 Functional dna clone for hepatitis c virus (hcv) and uses thereof |
| 09/11/1998 | WO1998039030A1 Vaccine composition for preventing or treating c hepatitis |
| 09/11/1998 | WO1998039028A1 Lyme combination compositions and uses |
| 09/11/1998 | WO1998031795A3 Novel human metallothionein |
| 09/11/1998 | WO1998031393A3 Polysaccharide-peptide-conjugates |
| 09/11/1998 | WO1998030692A3 Human endosulfine gene |
| 09/11/1998 | WO1998030687A3 Protein containing an srcr domain |
| 09/11/1998 | WO1998030584A3 Secreted proteins and polynucleotides encoding them |
| 09/11/1998 | WO1998029535A3 Nanoscale particles synthesized within an assembled virion |
| 09/11/1998 | WO1998029438A3 Cortistatin polypeptides |
| 09/11/1998 | WO1998028424A3 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily |
| 09/11/1998 | WO1998025956A3 Human GTP-binding proteins |
| 09/11/1998 | WO1998024912A3 Recombinant plague vaccine |
| 09/11/1998 | WO1998020135A3 Protease-activatable pseudomonas exotoxin a-like proproteins |
| 09/11/1998 | WO1998013488A3 Process for the determination of app secretase modulators and the use thereof as agents in the treatment of alzheimer's disease |
| 09/11/1998 | CA2284131A1 70 human secreted proteins |
| 09/11/1998 | CA2284083A1 Antigenic structural peptide, antigenic and immunogenic compounds and uses for detecting, preventing and treating an hcv infection |
| 09/11/1998 | CA2284078A1 A lymphocyte surface receptor that binds caml, nucleic acids encoding the same and methods of use thereof |
| 09/11/1998 | CA2283497A1 Vectors and methods for expression of mutant proteins |
| 09/11/1998 | CA2283459A1 Fas ligand compositions for treatment of proliferative disorders |
| 09/11/1998 | CA2283394A1 Methods and compositions for diagnosis and treatment of cancer |
| 09/11/1998 | CA2283379A1 Novel screening methods to identify agents that selectively inhibit hepatitis c virus replication |
| 09/11/1998 | CA2283299A1 186 human secreted proteins |
| 09/11/1998 | CA2283076A1 Vaccine composition for preventing or treating c hepatitis |
| 09/11/1998 | CA2282830A1 Sp.alpha.: a scavenger receptor cysteine-rich domain-containing polypeptide, and monoclonal antibodies thereto |
| 09/11/1998 | CA2282827A1 Method of alleviating neuropathic pain |
| 09/11/1998 | CA2282760A1 Human chemokine receptor-like chemokine |
| 09/11/1998 | CA2282717A1 Coxsackie virus vectors for delivery of nucleic acids encoding antigenic or therapeutic products |
| 09/11/1998 | CA2282709A1 Protein kinase c inhibitor-like protein (ipkc-2) |
| 09/11/1998 | CA2282708A1 Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof |
| 09/11/1998 | CA2282523A1 Species-specific yeast tfiib sequence |
| 09/11/1998 | CA2281862A1 Method of hybrid seed production using conditional female sterility |
| 09/11/1998 | CA2252422A1 Methods and reagents for modulating apoptosis |
| 09/11/1998 | CA2247799A1 Polynucleotides and polypeptides belonging to the uncoupling proteins family |
| 09/10/1998 | DE19709512A1 Recombinant influenza virus |
| 09/10/1998 | DE19709024A1 Polyasparaginsäure Homo- und Copolymere, ihre biotechnologische Herstellung und Verwendung Polyaspartic acid homo- and copolymers, their biotechnological production and use |
| 09/10/1998 | DE19708537A1 Neues Oberflächenprotein (SpsA-Protein) von Streptococcus pneumoniae etc. New surface protein (SpsA protein) of Streptococcus pneumoniae, etc. |
| 09/09/1998 | EP0863534A2 Plasma display panel device and method of fabricating the same |
| 09/09/1998 | EP0863211A1 Expression of recombinant fusion proteins in attenuated bacteria |
| 09/09/1998 | EP0863210A2 Immunoglobulin-binding artificial protein |
| 09/09/1998 | EP0863207A1 RNA dependent amidotransferase A from Staphylococcus Aureus |
| 09/09/1998 | EP0863206A2 Cytochrome P450 gene |
| 09/09/1998 | EP0863205A1 Def2 protein from Streptococcus pneumoniae |
| 09/09/1998 | EP0863204A1 Human cyclin i and gene encoding the same |